🇺🇸 FDA
Patent

US 7378386

Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 7378386 (Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives) held by The Board of Regents of the University of Texas System expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
77
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/62